Gastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor Prognosis
To access this article, please choose from the options below
Supported by the Swedish Cancer Society, Sahlgrenska Academy (the government ALF agreement), Inga-Britt and Arne Lundberg Research Foundation, Swedish Medical Research Foundation, Johan Jansson Foundation for Cancer Research, Assar Gabrielsson Research Foundation, Göteborg Medical Society, Capio Research Foundation, Björnsson Research Foundation, King Gustav V Jubilee Clinical Cancer Research Foundation, and Sahlgrenska University Hospital Research Foundation.
PII: S0016-5085(06)00071-0
doi:10.1053/j.gastro.2006.01.043
© 2006 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights reserved.

